lobbying_activities: 1109547

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1109547	043281b4-77b5-4d45-b117-9d7a631df327	Q2	CAUTHEN FORBES & WILLIAMS	284551	GENENTECH	2011	second_quarter	MMM	Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Medicare Prescription Drug Act of 2003]; Issues relating to Prescription Drug User Fee Act; issues related to comparative effectiveness and follow-on biologics, issues related to FDA repeal of Avastin, Issues related to coverage of Lucentis and Avastin.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2011-07-11T16:34:33.107000-04:00